Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00419705 · ClinicalTrials.gov registry record · Phase 3
Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)
A Phase 3 study, sponsored by PhotoThera.
- Completed
- Registry status
- Phase 3
- Development phase
- 660
- Enrollment target
NCT00419705 is a Phase 3 study that has completed, run by PhotoThera. The registered enrollment target is 660 participants.
The verdict
NCT00419705, a Phase 3 study, has completed, sponsored by PhotoThera.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 660 participants
- Enrollment target
Study Summary
The purpose of this pivotal study is to demonstrate safety and effectiveness of the NeuroThera® Laser System (referred to hereafter as NTS) in the treatment of Subjects diagnosed with acute ischemic stroke. The initiation of NTS treatment must be feasible for each Subject within 24 hours of stroke onset.
Interventions
- DEVICE NeuroThera® Laser System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2006-12 |
| Est. Completion | 2008-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00419705
The ClinicalTrials.gov registry entry for NCT00419705 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 660 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PhotoThera, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NeuroThera® Laser System is the first listed.
NCT00419705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00419705 about?
NCT00419705 is a clinical study titled "Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)". The purpose of this pivotal study is to demonstrate safety and effectiveness of the NeuroThera® Laser System (referred to hereafter as NTS) in the treatment of Subjects diagnosed with acute ischemic stroke. The initiation of NTS treatment must be feasible for each Subject within 24 hours of stroke o...
What is the current status of trial NCT00419705?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 660 participants. The study started on 2006-12. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00419705?
The interventions under investigation include: NeuroThera® Laser System (DEVICE).
Who is sponsoring clinical trial NCT00419705?
This trial is sponsored by PhotoThera, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.